Cheaper weight-loss drugs were expected to take off in India. But despite GLP-1s costing as little as $14 a month, demand has been slower than expected. From stigma to hesitant doctors, Satviki Sanjay explains why price isn’t the only barrier. (Source: Bloomberg)
CryptoAlerta — análise de criptomoedas e mercado em tempo real